β-Gal enzyme activity driven by the HSV LAT promoter does not correspond to β-gal RNA levels in mouse trigeminal ganglia

Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.